Rare Disease Summit is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


John Reynders
Vice President, R&D Strategy, Program Management & Data Sciences at Alexion Pharmaceuticals, Inc.

Agenda Sessions

  • Technology Spotlight Keynote